CLINICAL_TRIALS
trial_result
· 2021-03-22
Clinical Trial Update: neoadjuvant_thymic Epithelial Tumor [Phase 2]
Summary
A Phase 2 clinical trial update for neoadjuvant therapy in thymic epithelial tumor, status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Samsung Medical Center | Conditions: Thymic Epithelial Tumor | Phase 2 | Status: UNKNOWN